IDERA PHARMACEUTICALS, INC.

AMPLIVAX

Ingredients for pharmaceutical compositions, namely, adjuvants to enhance an immune system response, marketed solely to manufactures of vaccines;AMPLIFY VACCINE;

GEM

biologically active compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes;

HYBRIDON

medical diagnostic and therapeutic preparations; namely, biologically active modulators and anti-sense DNA compounds, chemical modulators of gene expression working at DNA, transcription, RNA or translation processes;

HYBRIDON

medical diagnostic and therapeutic preparations; namely, biologically active modulators and anti-sense DNA compounds, chemical modulators of gene expression working at DNA, transcription, RNA or translation processes;

IDERA

The mark consists of the word idera and a design element. The design element is positioned above and to the left of the word idera and consists of six circles around a common center. Four of those circles are connected to matching circles such that they resemble cells that are in the act of splitting. One of the two other circles forms the dot in the letter i in idera.;Pharmaceuticals for use in the treatment of cancer;Color is not claimed as a feature of the mark.;